A promising molecular diagnostic tool for detecting primary bladder cancer in patients who notice blood in their urine may speed up diagnosis and reduce the need for potentially unnecessary ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced new data that reinforce the ability of its Decipher Bladder Genomic ...
Protect your bladder health with these 5 essential health checks. Learn which tests and screenings you need to maintain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback